Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.16.3.1 (
ceruloplasmin
)
5,074
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lipid peroxidation (LPX) products in plasma were elevated in
Duchenne muscular dystrophy (DMD)
patients (n = 9) compared with an age- and sex-matched group of controls (n = 10). Trichloroacetic acid-precipitable thiobarbituric acid-reactive substances (TBARS) were increased by 35% (p less than 0.01), conjugated dienes by 77% (p less than 0.02) and fluorescent pigments (FP) by 70% (p less than 0.001). Plasma alpha-tocopherol was significantly decreased, by 50%, in
DMD
compared with healthy subjects (p less than 0.002). In conjunction with the finding of others of a deficiency in
DMD
of the plasma lipoproteins which normally transport vitamin E to the tissues, this may contribute to the increased LPX seen in the disease especially if muscle damage also liberates free Fe2+. The major circulating antioxidant protein,
caeruloplasmin
(CP), was significantly increased (p less than 0.001) by 25-30% in
DMD
patients compared with both adult and young male controls. In
DMD
patients only, this increase is correlated with the concentration of TBARS and FP suggesting that increased LPX may be a trigger for CP synthesis.
...
PMID:Plasma antioxidants and lipid peroxidation products in Duchenne muscular dystrophy. 369 11